P18
General Information
DRACP ID DRACP00229
Peptide Name P18
Sequence KWKLFKKIPKFLHLAKKF
Sequence Length 18
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
M14 | Amelanotic melanoma | Carcinoma | 92.2 ± 1.02% cell viability at 10 µM, 71.1 ± 2.84% cell viability at 20 µM, 50 ± 3.09% cell viability at 40 µM, 31.5 ± 1.49% cell viability at 60 µM, 13.8 ± 1.44% cell viability at 80 µM | MTT assay | Not available | 1 |
A-375 | Amelanotic melanoma | Carcinoma | 86 ± 0.57% cell viability at 10 µM, 63.8 ± 0.8% cell viability at 20 µM, 47.5 ± 1.66% cell viability at 40 µM, 26.9 ± 0.5% cell viability at 60 µM, 6.5 ± 1.07% cell viability at 80 µM | MTT assay | Not available | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity 99 ± 1.6% cell viability at 10 µM, 98 ± 1.6% cell viability at 20 µM, 75.2 ± 5.6% cell viability at 40 µM, 70.8 ± 3.6% cell viability at 60 µM, 47.7 ± 3.1% cell viability at 80 µM
Target Not available
Affinity Not available
Mechanism Amphiphilic α-helical structure of P18 peptide, coupled with changes in ion channels and an increase in plasma membrane permeability that eventually leads to melanoma cell death
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C118H186N28O19
Absent amino acids CDEGMNQRSTVY
Common amino acids K
Mass 260436
Pl 11.58
Basic residues 8
Acidic residues 0
Hydrophobic residues 9
Net charge 8
Boman Index -1075
Hydrophobicity -38.33
Aliphatic Index 92.22
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: >10 hour
Extinction Coefficient cystines 5500
Absorbance 280nm 323.53
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 19957017
Title Anti-melanoma activity of hybrid peptide P18 and its mechanism of action
Year 2010
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available